cobaltous chloride has been researched along with Adenocarcinoma of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, S; Han, Y; Li, X; Wang, X; Wang, Y; Yang, Y; Zhang, Z | 1 |
| Belinsky, SA; Bernauer, AM; Liu, Y; Yingling, CM | 1 |
2 other study(ies) available for cobaltous chloride and Adenocarcinoma of Lung
| Article | Year |
|---|---|
UCP2 inhibits ROS-mediated apoptosis in A549 under hypoxic conditions.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cobalt; Down-Regulation; Gene Expression; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ion Channels; Lung Neoplasms; Mitochondrial Proteins; Oxygen; Reactive Oxygen Species; RNA, Small Interfering; Transfection; Uncoupling Protein 2 | 2012 |
HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Cobalt; DNA Repair; DNA-Binding Proteins; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; RNA Interference; RNA, Small Interfering; Transcription, Genetic; Xeroderma Pigmentosum Group A Protein | 2012 |